Effect of the Combination of Methotrexate and Adalimumab on Reduction of Immunization in Ankylosing Spondylitis (COMARIS)
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if association of methotrexate with adalimumab
leads to decrease immunogenicity beside adalimumab alone in Ankylosing Spondylitis.